Clinical tryals of tolerability and safety of lyophilic «layfferon», 9 000 000 iu for intramuscular solution with participation of healthy volunteers

Natalia N. Ryndyuk; Рындюк Наталья Николаевна; Zoya I. Ginko; Гинько Зоя Ивановна; Roman P. Aleynikov; Алейников Роман Павлович; Iliy V. Vasilevich; Василевич Илья Владимирович; Vladimir I.  Kuzubov; Кузубов Владимир Иванович; Svetlana V. Usova; Усова Светлана Владимировна; Olga N. Muhina; Мухина Ольга Николаевна; Maryana G. Sharypova; Шарыпова Марьяна Григорьевна; Sergey N. Targonskiy; Таргонский Сергей Николаевич

doi:10.17816/clinpract1435-40

Clinical tryals of tolerability and safety of lyophilic «layfferon», 9 000 000 iu for intramuscular solution with participation of healthy volunteers

Authors: Ryndyuk N.N.¹, Ginko Z.I.¹, Aleynikov R.P.¹, Vasilevich I.V.¹, Kuzubov V.I.¹, Usova S.V.², Muhina O.N.², Sharypova M.G.², Targonskiy S.N.²
Affiliations:
1. FGUZ Medical and sanitary unit No. 163 FMBA of Russia
2. CJSC "Vector-Medica"
Issue: Vol 1, No 4 (2010)
Pages: 35-40
Section: Articles
URL: https://journals.rcsi.science/clinpractice/article/view/8182
DOI: https://doi.org/10.17816/clinpract1435-40
ID: 8182

Cite item

Full Text

Abstract
Full Text
About the authors
References
Statistics

Abstract

In the article results of clinical tryal of the new drug containing interferon – Layfferon, 9000000 IUintramuscular solution in healthy volunteers are presented.Safety and tolerability of the new dosage of Layfferon was estimated on the basis of supervision over a condition of volunteers, clinical and laboratory inspection within 30 day after introduction of a preparation.As a result of test it has been established, that Layfferone a doze 9 000 000 IUt is safe and tolerated. Study results have allowed to create the instruction on application for new dosage of the drug.